evaluating nimotuzumab

Related by string. * EVALUATING . EVALUATED . Evaluated . evaluated . Evaluating : evaluating CK # . When evaluating Antigenics . rigorously evaluated . Intervention Trial Evaluating . evaluating OGX . prospectively evaluated . evaluating Nexavar . evaluating ispinesib . evaluating pirfenidone / Nimotuzumab : products nimotuzumab humanized . Nimotuzumab anti . nimotuzumab * *

Related by context. Frequent words. (Click for all words.) 59 Phase III randomized 58 phase IIb 57 Phase III pivotal 57 randomized Phase III 56 pivotal Phase III 56 multicenter clinical 56 confirmatory Phase 3 56 phase IIa 56 Phase 2b clinical 56 Phase 1b trial 56 Phase III clinical 55 Phase 1b clinical 55 dose escalation trial 55 Phase Ib 55 Phase IIb 54 phase 2a 54 label dose escalation 54 Phase IIb clinical 54 placebo controlled randomized 54 Phase 2a clinical 54 Phase 2b 54 Phase Ia 54 HGS ETR1 54 Phase 1b 53 Phase 2b trial 53 randomized Phase 53 confirmatory Phase III 52 Investigational Device Exemption IDE 52 Phase III 52 multicenter randomized double 52 blinded placebo controlled 52 Phase 2b study 52 tesmilifene 52 Phase IIa trial 52 Phase 2a trial 51 multicenter randomized 51 randomized placebo controlled 51 blind randomized placebo 51 Phase IIa clinical 51 Phase 2a 51 Phase II 51 pivotal Phase 51 IMC A# 51 randomized clinical 51 randomized double 50 Phase IIb trial 50 multicentre 50 nab paclitaxel 49 axitinib 49 blind randomized 49 Phase III clinical trials 49 % #F# 3v.jsn 49 IIa clinical trial 48 plus prednisone 48 Phase IIa 48 prospective randomized 48 multicenter 48 rNAPc2 48 ZYBRESTAT 48 randomized controlled 48 MOZOBIL 48 RG# [001] 48 PROPEL 48 placebo controlled 47 relapsed multiple myeloma 47 active comparator 47 Completes Enrollment 47 BAY #-# 47 prospective randomized controlled 47 Phenoptin 47 Phase 1a 47 Phase III Trial 47 dose escalation study 47 ozarelix 46 romidepsin 46 dose escalation 46 SPIRIT III 46 tesetaxel 46 ocrelizumab 46 BCX# 46 single ascending dose 46 ThermoDox ® 46 double blind placebo 46 tezampanel 46 multiple ascending dose 45 clinical trial 45 blind placebo controlled 45 investigational oral 45 Projected completion 45 TELCYTA 45 Board DSMB 45 randomized controlled clinical 45 PRX # 44 dose cohorts 44 OXi# 44 sapacitabine 44 MDV# 44 PROPEL trial 44 talactoferrin 44 multicenter study 44 CRx

Back to home page